«12345»Seite
5 articles with references, page 1 of 5

Review article

Nocebo Phenomena in Medicine: Their Relevance in Everyday Clinical Practice

Dtsch Arztebl Int 2012; 109(26): 459-65; DOI: 10.3238/arztebl.2012.0459

Häuser, W; Hansen, E; Enck, P

1. Hróbjartsson A, Gøtzsche PC: Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010; (1): CD003974. MEDLINE
2. Wissenschaftlicher Beirat der Bundesärztekammer: Stellungnahme des Wissenschaftlichen Beirats der Bundesärztekammer „Placebo in der Medizin“. www.bundesaerztekammer.de/downloads/StellPlacebo 2010.pdf, Last accessed on 09 November 2011.
3. Kennedy WP: The nocebo reaction. Med World 1961; 95: 203–5. MEDLINE
4. Colloca L, Sigaudo M, Benedetti F: The role of learning in nocebo and placebo effects. Pain 2008; 136: 211–8. CrossRef MEDLINE
5. Colloca L, Miller FG: The nocebo effect and its relevance for clinical practice. Psychosom Med 2011; 73: 598–603. CrossRef MEDLINE
6. Enck P, Benedetti F, Schedlowski M: New insights into the placebo and nocebo responses. Neuron 2008; 59: 195–206. CrossRef MEDLINE
7. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P: Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 2009; 66: 323–8. CrossRef MEDLINE
8. Benedetti F, Lanotte M, Lopiano L, Colloca L: When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007; 147: 260–71. CrossRef MEDLINE
9.Colloca L, Benedetti F: Placebo analgesia induced by social observational learning. Pain 2009; 144: 28–34. CrossRef MEDLINE
10. Pfingsten M, Leibing E, Harter W, et al.: Fear-avoidance behavior and anticipation of pain in patients with chronic low back pain: a randomized controlled study. Pain Med 2001; 2: 259–66. CrossRef MEDLINE
11. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK: Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008; 65: 220–31. CrossRef MEDLINE
12. Benedetti F, Amanzio M, Vighetti S, Asteggiano G: The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26: 12014–22. CrossRef MEDLINE
13. Mitsikostas DD: Nocebo in headaches: implications for clinical practice and trial design. Curr Neurol Neurosci Rep 2012; 12: 132–7. CrossRef MEDLINE
14. Hansen E, Bejenke C: Negative und positive Suggestionen in der Anästhesie – Ein Beitrag zu einer verbesserten Kommunikation mit ängstlichen Patienten bei Operationen. Anaesthesist 2010; 59: 199–209. CrossRef MEDLINE
15. Bejenke CJ: Suggestive communication: its wide applicability in somatic medicine. In: Varga K (ed.). Beyond the words: communication and suggestion in medical practice. New York: Nova Science Publishers 2011; 83–96.
16. Cheek D: Importance of recognizing that surgical patients behave as though hypnotized. Am J ClinHypnosis 1962; 4: 227–31. CrossRef MEDLINE
17. Lang EV, Benotsch EG, Fick LJ, et al.: Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. Lancet 2000; 355: 1486–90. CrossRef MEDLINE
18. Varelmann D, Pancaro C, Cappiello EC, Camann WR: Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg 2010; 110: 868–70. CrossRef MEDLINE
19. Ernst E, Resch KL: Concept of true and perceived placebo effects. BMJ 1995; 311: 551–3. CrossRef MEDLINE PubMed Central
20. Amanzio M, Corazzini LL, Vase L: A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009; 146: 261–9. CrossRef MEDLINE
21. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, et al.: Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf 2009; 32: 1041–56. CrossRef MEDLINE
22. Häuser W, Bartram C, Bartram-Wunn E, Tölle T: Systematic review: Adverse events attributable to nocebo in randomised controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy. Clin J Pain 2012; 28: 437–51. CrossRef MEDLINE
23. Vernia P, Di Camillo M, Foglietta T: Diagnosis of lactose intolerance and the „nocebo“ effect: the role of negative expectations. Dig Liver Dis 2010; 42: 616–9. CrossRef MEDLINE
24. Weissenfeld J, Stock S, Lüngen M, Gerber A: The nocebo effect: a reason for patients’ non-adherence to generic substitution? Pharmazie 2010; 65: 451–6. MEDLINE
25. Miller FG, Colloca L: The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth 2011; 32: 229–43. CrossRef MEDLINE
e1. Lown B: Die verlorene Kunst des Heilens. Stuttgart: Schattauer, 2004.
e2. Beecher HK: The powerful placebo. J Am Med Assoc 1955; 159: 1602–6. MEDLINE
e3.Furmark T, Appel L, Henningsson S, et al.: A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008; 28: 13066–74. MEDLINE
e4.Kaptchuk TJ, Kelley JM, Deykin A, et al.: Do „placebo responders“ exist? Contemp Clin Trials 2008; 29: 587–95. MEDLINE
e5.Hansen E, Zimmermann M, Dünzl G: Hypnotische Kommunikation mit Notfallpatienten. Notfall Rettungsmed 2010; 13: 314–21. CrossRef
e6. Hansen E: Negativsuggestionen in der Medizin. Z Hypnose Hypnother 2011; 6: 65–82.
e7. Stovner LJ, Oftedal G, Straume A, Johnsson A: Nocebo as headache trigger: evidence from a sham-controlled provocation study with RF fields. Acta Neurol Scand 2008; 188 (Suppl): 67–71. MEDLINE MEDLINE
e8. Mercado R, Constantoyannis C, Mandat T, Kumar A: Expectation and the placebo effect in Parkinson`s disease patients with subthalamic nucleus deep brain stimulation. Movement Disorders 2006; 21: 1457–11461. CrossRef
e9.Rief W, Avorn J, Barsky AJ: Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 2006; 166: 155–60. MEDLINE
e10. Papadopoulos D, Mitsikostas DD: Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler 2010; 16: 816–28. CrossRef MEDLINE
e11. Mitsikostas DD, Mantonakis LI, Chalarakis NG: Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia 2011; 31: 550–61. CrossRef MEDLINE
e12.Liccardi G, Senna G, Russo M, et al.: Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Investig Allergol Clin Immunol 2004; 14: 104–7. MEDLINE
e13. Lombardi C, Gargioni S, Canonica GW, Passalacqua G: The nocebo effect during oral challenge in subjects with adverse drug reactions. Eur Ann Allergy Clin Immunol 2008; 40: 138–41. MEDLINE
e14. de la Cruz M, Hui D, Parsons HA, Bruera E: Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 2010; 116: 766–74. CrossRef MEDLINE PubMed Central
e15. Manchikanti L, Pampati VKim Damron K: The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician 2005; 8: 349–55. MEDLINE
e16. Mondaini N, Gontero P, Giubilei G, et al.: Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 2007; 4: 1708–12. MEDLINE
e17. Silvestri A, Galetta P, Cerquetani E, et al.: Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 2003; 24: 1928–32. MEDLINE
e18. Cocco G: Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology 2009; 112: 174–7. CrossRef MEDLINE
e19. Cairns JA, Gent M, Singer J, et al.: Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985; 313: 1369–75. MEDLINE
e20. Myers MG, Cairns JA, Singer J: The consent form as a possible cause of side effects. Clin Pharmacol Ther 1987; 42: 250–3. CrossRef MEDLINE
e21. Reeves RR, Ladner ME, Hart RH, Burke RS: Nocebo effects with antidepressant clinical drug trial placebos. Gen Hosp Psychiatry 2007; 29: 275–7. CrossRef MEDLINE
e22. Resolution des Deutschen Schmerztages 2008. Sparmaßnahmen im Gesundheitswesen verletzen Grundrecht auf Leben und körperliche Unversehrtheit. www.schmerz-therapie-deutschland.de/pages/presse/2008/2008_03_08_PM_12_Resolution.pdf. Last accessed on 18 September 2011.
e23. Koch M: Petitionsausschuss Deutscher Bundestag 9.5.2011. www.bundestag.de/dokumente/textarchiv/2011/34316512_kw19_pa_petitionen/index.html. Last accessed on 18 September 2011.
e24. Colagiuri B, Zachariae R: Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med 2010; 40: 3–14. CrossRef MEDLINE
e25. Bundesärztekammer: Empfehlungen zur Patientenaufklärung. Dtsch Arztebl 1990; 87(16): 807–8. VOLLTEXT
e26.O’Connor AM, Pennie RA, Dales RE: Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. J Clin Epidemiol 1996; 49: 1271–6. CrossRef MEDLINE
e27. Dworkin G: The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press; 1988.
e28. Bennett MI, Bagnall AM, Raine G, et al.: Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain 2011; 27: 623–30. MEDLINE
e29. Bosse HM, Schultz JH, Nickel M, et al.: The effect of using standardized patients or peer role play on ratings of undergraduate communication training: A randomized controlled trial. Patient Educ Couns; 2011 (epub ahead of print). MEDLINE
e30.Bosse HM, Nickel M, Huwendiek S, Jünger J, Schultz JH, Nikendei C: Peer role-play and standardised patients in communication training: a comparative study on the student perspective on acceptability, realism, and perceived effect. BMC Med Educ 2010; 10: 27. CrossRef MEDLINE PubMed Central